[Federal Register Volume 62, Number 47 (Tuesday, March 11, 1997)]
[Notices]
[Page 11216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6007]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute of Allergy and Infectious Diseases Special Emphasis
Panel (SEP) meetings:
Name of SEP: Expanded Research on Emerging Diseases (Telephone
Conference Call).
Date: March 19, 1997.
Time: 10:00 a.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Peter R. Jackson, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD
20892, (301) 496-2550.
Purpose/Agenda: To evaluate a grant application.
Name of SEP: Mechanisms of Immunopathology in DHF/DSS (Telephone
Conference Call).
Date: March 20, 1997.
Time: 10:00 a.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Peter R. Jackson, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD
20892, (301) 496-2550.
Purpose/Agenda: To evaluate a grant application.
This notice is being published less than 15 days prior to the
above meetings due to the urgent need to meet timing limitations
imposed by the review and funding cycle.
Name of SEP: Expanded Research on Emerging Diseases (Telephone
Conference Call).
Date: April 3, 1997.
Time: 2:00 p.m.
Place: Teleconference, 6003 Executive Boulevard, Solar Bldg.,
Room 4C10, Bethesda, MD 20892, (301) 496-2550.
Contact Person: Dr. Peter R. Jackson, Scientific Review Adm.,
6003 Executive Boulevard, Solar Bldg., Room 4C10, Bethesda, MD
20892, (301) 496-2550.
Purpose/Agenda: To evaluate a grant application.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.855,
Immunology, Allergic and Immunologic Diseases Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health.)
Dated: March 5, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-6007 Filed 3-10-97; 8:45 am]
BILLING CODE 4140-01-M
